{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:08:51Z","timestamp":1792822131812,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Chemotherapy-induced alopecia (CIA) is a distressing side effect of cancer treatment with significant psychosocial consequences. Scalp cooling therapy (SCT) reduces the risk of CIA, but variability in pre- and post-infusion cooling durations limits its standardization and broader implementation. This review aims to examine current practices, identify factors contributing to variation, and explore strategies for optimizing SCT protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a narrative review of published literature on SCT, including studies evaluating efficacy across chemotherapy regimens, SCT duration, patient factors such as hair type and race, and institutional barriers. We also reviewed studies assessing innovations aimed at reducing chair time and improving feasibility of SCT delivery in diverse clinical settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pre-cooling durations typically range from 5\u201330\u00a0min, while post-cooling times vary from 15\u00a0min to 4\u00a0h, often without clear evidence for longer durations. Taxane-based regimens show higher hair preservation success compared to anthracyclines. Patient-specific factors (e.g., hair texture, race), staff availability, chair time, and equipment limitations all impact SCT implementation. Portable SCT systems and cooling stations outside the infusion chair have been proposed to improve workflow. Limited data suggest shorter post-cooling may be equally effective and better tolerated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SCT is an effective intervention for CIA, but wide variation in implementation presents challenges. Standardizing cooling durations based on evidence and patient-centered considerations is essential to improve SCT access, patient satisfaction, and healthcare efficiency. Further research is needed to evaluate shortened protocols, portable systems, and pharmacologic adjuncts that may enhance the feasibility and effectiveness of SCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-025-10058-y","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:33:37Z","timestamp":1761968017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Scalp cooling therapy in chemotherapy-induced alopecia: addressing variability in cooling duration and efficacy"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8761-3162","authenticated-orcid":false,"given":"Lily","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2318-5488","authenticated-orcid":false,"given":"Lilia","family":"Valentic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-1681","authenticated-orcid":false,"given":"Lauren","family":"Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0605-1020","authenticated-orcid":false,"given":"Christina","family":"Icksarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2741-3951","authenticated-orcid":false,"given":"Lucy","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3043-8903","authenticated-orcid":false,"given":"Brittany","family":"Dulmage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"issue":"4","key":"10058_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/pon.1245","volume":"17","author":"J Lemieux","year":"2008","unstructured":"Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology 17(4):317\u2013328. https:\/\/doi.org\/10.1002\/pon.1245","journal-title":"Psychooncology"},{"issue":"2","key":"10058_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1188\/25.ONF.126-136","volume":"52","author":"A \u00c7elik","year":"2025","unstructured":"\u00c7elik A, \u00c7inar D, \u00d6zt\u00fcrk \u00c7etin A, \u00dcmit \u00dcnal O (2025) The effect of chemotherapy-induced alopecia on distress and quality of life in male patients with cancer. Oncol Nurs Forum 52(2):126\u2013136. https:\/\/doi.org\/10.1188\/25.ONF.126-136","journal-title":"Oncol Nurs Forum"},{"key":"10058_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ygyno.2024.06.012","volume":"188","author":"KA Lambert","year":"2024","unstructured":"Lambert KA, Albright BB, Anastasio MK, Kaplan SJ, McNally L (2024) Scalp hypothermia to reduce chemotherapy-induced alopecia: a systematic review and meta-analysis. Gynecol Oncol 188:71\u201380. https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.012","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10058_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00520-024-08393-7","volume":"32","author":"D Weaver","year":"2024","unstructured":"Weaver D, Pershing ML, Golden B, Hammel L, Russ PK, Cripe M (2024) Retrospective evaluation of Penguin cold caps for chemotherapy-induced alopecia. Support Care Cancer 32(4):225. https:\/\/doi.org\/10.1007\/s00520-024-08393-7","journal-title":"Support Care Cancer"},{"issue":"4","key":"10058_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/NCC.0000000000001234","volume":"47","author":"M Contreras Molina","year":"2024","unstructured":"Contreras Molina M, \u00c1lvarez Bueno C, Cavero Redondo I, Lucer\u00f3n Lucas-Torres MI, Jim\u00e9nez L\u00f3pez E, Garc\u00eda Maestro A (2024) Effectiveness of scalp cooling to prevent chemotherapy-induced alopecia in patients undergoing breast cancer treatment: a systematic review and meta-analysis. Cancer Nurs 47(4):319\u2013326. https:\/\/doi.org\/10.1097\/NCC.0000000000001234","journal-title":"Cancer Nurs"},{"key":"10058_CR6","unstructured":"Rugo HS, van den Hurk C (2024) Alopecia related to systemic cancer therapy. In: Drews RE, Hordinsky M, Vora SR (eds) UpToDate. Wolters Kluwer; Updated August 14, 2024. https:\/\/www.uptodate.com\/contents\/alopecia-related-to-systemic-cancer-therapy?search=scalp%20cooling&source=search_result&selectedTitle=1%7E11&usage_type=default&display_rank=1#H7. Accessed 6 May 2025"},{"issue":"21\u201322","key":"10058_CR7","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1111\/jocn.16160","volume":"31","author":"S Renehan","year":"2022","unstructured":"Renehan S, Tencic M, Jackson K, Krishnasamy M (2022) Improving preparation for scalp cooling: learning from women undergoing chemotherapy for early-stage breast cancer-the COOL study. J Clin Nurs 31(21\u201322):3222\u20133234. https:\/\/doi.org\/10.1111\/jocn.16160","journal-title":"J Clin Nurs"},{"issue":"7","key":"10058_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00520-024-08611-2","volume":"32","author":"BE Ueberroth","year":"2024","unstructured":"Ueberroth BE, Kosiorek HE, Nafissi NN et al (2024) Patient and nursing staff perspectives on automated scalp cooling (ASC) for chemotherapy-induced alopecia in breast cancer. Support Care Cancer 32(7):412. https:\/\/doi.org\/10.1007\/s00520-024-08611-2","journal-title":"Support Care Cancer"},{"issue":"5","key":"10058_CR9","doi-asserted-by":"publisher","first-page":"E442","DOI":"10.1002\/ijc.29115","volume":"136","author":"H Shin","year":"2015","unstructured":"Shin H, Jo SJ, Kim DH, Kwon O, Myung SK (2015) Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer 136(5):E442\u2013E454. https:\/\/doi.org\/10.1002\/ijc.29115","journal-title":"Int J Cancer"},{"issue":"6","key":"10058_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3109\/00365518509155250","volume":"45","author":"J B\u00fclow","year":"1985","unstructured":"B\u00fclow J, Friberg L, Gaardsting O, Hansen M (1985) Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man. Scand J Clin Lab Invest 45(6):505\u2013508. https:\/\/doi.org\/10.3109\/00365518509155250","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"10058_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1188\/18.CJON.534-541","volume":"22","author":"E Fischer-Cartlidge","year":"2018","unstructured":"Fischer-Cartlidge E, Ross M, Hern\u00e1ndez K, Featherstone A, Haase C (2018) Scalp cooling: implementation of a program at a multisite organization. Clin J Oncol Nurs 22(5):534\u2013541. https:\/\/doi.org\/10.1188\/18.CJON.534-541","journal-title":"Clin J Oncol Nurs"},{"issue":"3","key":"10058_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1200\/JOP.17.00038","volume":"14","author":"M Kruse","year":"2018","unstructured":"Kruse M, Abraham J (2018) Management of chemotherapy-induced alopecia with scalp cooling. J Oncol Pract 14(3):149\u2013154. https:\/\/doi.org\/10.1200\/JOP.17.00038","journal-title":"J Oncol Pract"},{"issue":"7","key":"10058_CR13","first-page":"5","volume":"15","author":"RM Tr\u00fceb","year":"2010","unstructured":"Tr\u00fceb RM (2010) Chemotherapy-induced hair loss. Skin Therapy Lett 15(7):5\u20137","journal-title":"Skin Therapy Lett"},{"issue":"5","key":"10058_CR14","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00520-018-4432-6","volume":"27","author":"MMC Komen","year":"2019","unstructured":"Komen MMC, van den Hurk CJG, Nortier JWR et al (2019) Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy. Support Care Cancer 27(5):1919\u20131925. https:\/\/doi.org\/10.1007\/s00520-018-4432-6","journal-title":"Support Care Cancer"},{"issue":"12","key":"10058_CR15","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00520-012-1465-0","volume":"20","author":"CJ van den Hurk","year":"2012","unstructured":"van den Hurk CJ, Breed WP, Nortier JW (2012) Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 20(12):3255\u20133260. https:\/\/doi.org\/10.1007\/s00520-012-1465-0","journal-title":"Support Care Cancer"},{"issue":"6","key":"10058_CR16","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00520-016-3084-7","volume":"24","author":"MM Komen","year":"2016","unstructured":"Komen MM, Breed WP, Smorenburg CH et al (2016) Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 24(6):2735\u20132741. https:\/\/doi.org\/10.1007\/s00520-016-3084-7","journal-title":"Support Care Cancer"},{"issue":"8","key":"10058_CR17","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1007\/s00520-022-07090-7","volume":"30","author":"RT Lugtenberg","year":"2022","unstructured":"Lugtenberg RT, van den Hurk CJG, Smorenburg CH et al (2022) Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial. Support Care Cancer 30(8):6641\u20136648. https:\/\/doi.org\/10.1007\/s00520-022-07090-7","journal-title":"Support Care Cancer"},{"issue":"26","key":"10058_CR18","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1200\/JCO.23.02374","volume":"42","author":"D Kang","year":"2024","unstructured":"Kang D, Cho J, Zhao D et al (2024) Scalp cooling in preventing persistent chemotherapy-induced alopecia: a randomized controlled trial. J Clin Oncol 42(26):3115\u20133122. https:\/\/doi.org\/10.1200\/JCO.23.02374","journal-title":"J Clin Oncol"},{"issue":"2","key":"10058_CR19","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1200\/OP.21.00273","volume":"18","author":"M Novice","year":"2022","unstructured":"Novice M, Novice T, Henry NL et al (2022) Identifying barriers and facilitators to Scalp Cooling Therapy through a national survey of the awareness, practice patterns, and attitudes of oncologists. JCO Oncol Pract 18(2):e225\u2013e234. https:\/\/doi.org\/10.1200\/OP.21.00273","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10058_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00520-017-3849-","volume":"26","author":"JM Shaw","year":"2018","unstructured":"Shaw JM, O\u2019Brien J, Chua S et al (2018) Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals\u2019 attitudes to and experience with scalp cooling. Support Care Cancer 26(1):305\u2013312. https:\/\/doi.org\/10.1007\/s00520-017-3849-","journal-title":"Support Care Cancer"},{"issue":"5","key":"10058_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/jdv.14612","volume":"32","author":"VV Shah","year":"2018","unstructured":"Shah VV, Wikramanayake TC, DelCanto GM et al (2018) Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials. J Eur Acad Dermatol Venereol 32(5):720\u2013734. https:\/\/doi.org\/10.1111\/jdv.14612","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10058_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10549-020-05968-w","volume":"185","author":"C Villarreal-Garza","year":"2021","unstructured":"Villarreal-Garza C, Mesa-Chavez F, Garza-Ledezma MRA et al (2021) Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention. Breast Cancer Res Treat 185(2):453\u2013458. https:\/\/doi.org\/10.1007\/s10549-020-05968-w","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10058_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/onco.13690","volume":"26","author":"A Dilawari","year":"2021","unstructured":"Dilawari A, Gallagher C, Alintah P et al (2021) Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer? Oncologist 26(4):292-e548. https:\/\/doi.org\/10.1002\/onco.13690","journal-title":"Oncologist"},{"issue":"30","key":"10058_CR24","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1200\/JCO.20.02130","volume":"38","author":"EF Araoye","year":"2020","unstructured":"Araoye EF, Stearns V, Aguh C (2020) Considerations for the use of scalp cooling devices in Black patients. J Clin Oncol 38(30):3575\u20133576. https:\/\/doi.org\/10.1200\/JCO.20.02130","journal-title":"J Clin Oncol"},{"issue":"2","key":"10058_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/hex.13679","volume":"26","author":"J Delgado Rodr\u00edguez","year":"2023","unstructured":"Delgado Rodr\u00edguez J, Ramos-Garc\u00eda V, Infante-Ventura D et al (2023) Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy-induced alopecia: a systematic review. Health Expect 26(2):567\u2013578. https:\/\/doi.org\/10.1111\/hex.13679","journal-title":"Health Expect"},{"issue":"3","key":"10058_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1188\/19.CJON.237-241","volume":"23","author":"M Heery","year":"2019","unstructured":"Heery M, Cohen S, Mena Z (2019) Scalp Cooling: Implementing a Cold Cap Program at a Community Breast Health Center. Clin J Oncol Nurs 23(3):237\u2013241. https:\/\/doi.org\/10.1188\/19.CJON.237-241","journal-title":"Clin J Oncol Nurs"},{"issue":"3","key":"10058_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2354.2001.00272.x","volume":"10","author":"D Batchelor","year":"2001","unstructured":"Batchelor D (2001) Hair and cancer chemotherapy: consequences and nursing care\u2013a literature study. Eur J Cancer Care (Engl) 10(3):147\u2013163. https:\/\/doi.org\/10.1046\/j.1365-2354.2001.00272.x","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"2","key":"10058_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s0959-8049(96)00374-7","volume":"33","author":"M Lemenager","year":"1997","unstructured":"Lemenager M, Lecomte S, Bonneterre ME, Bessa E, Dauba J, Bonneterre J (1997) Effectiveness of cold cap in the prevention of docetaxel-induced alopecia. Eur J Cancer 33(2):297\u2013300. https:\/\/doi.org\/10.1016\/s0959-8049(96)00374-7","journal-title":"Eur J Cancer"},{"issue":"2","key":"10058_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/030089161009600214","volume":"96","author":"PK Auvinen","year":"2010","unstructured":"Auvinen PK, M\u00e4h\u00f6nen UA, Soininen KM et al (2010) The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia. Tumori 96(2):271\u2013275. https:\/\/doi.org\/10.1177\/030089161009600214","journal-title":"Tumori"},{"issue":"6262","key":"10058_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/bmj.282.6262.423","volume":"282","author":"JE Anderson","year":"1981","unstructured":"Anderson JE, Hunt JM, Smith IE (1981) Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer. Br Med J (Clin Res Ed) 282(6262):423\u2013424. https:\/\/doi.org\/10.1136\/bmj.282.6262.423","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10058_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1200\/JCO.1983.1.1.33","volume":"1","author":"JC Dean","year":"1983","unstructured":"Dean JC, Griffith KS, Cetas TC, Mackel CL, Jones SE, Salmon SE (1983) Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopecia. J Clin Oncol 1(1):33\u201337. https:\/\/doi.org\/10.1200\/JCO.1983.1.1.33","journal-title":"J Clin Oncol"},{"key":"10058_CR32","doi-asserted-by":"publisher","unstructured":"Tollenaar RA, Liefers GJ, Repelaer van Driel OJ, van de Velde CJ (1994) Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.\u00a0Eur J Cancer 30A(10):1448\u20131453. https:\/\/doi.org\/10.1016\/0959-8049(94)00280-i","DOI":"10.1016\/0959-8049(94)00280-i"},{"issue":"7","key":"10058_CR33","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00520-024-08579-z","volume":"32","author":"E Carton","year":"2024","unstructured":"Carton E, Blas AM, Perret C, Le Bihan M (2024) Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study. Support Care Cancer 32(7):410. https:\/\/doi.org\/10.1007\/s00520-024-08579-z","journal-title":"Support Care Cancer"},{"issue":"6","key":"10058_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jama.2016.20939","volume":"317","author":"J Nangia","year":"2017","unstructured":"Nangia J, Wang T, Osborne C et al (2017) Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial. JAMA 317(6):596\u2013605. https:\/\/doi.org\/10.1001\/jama.2016.20939","journal-title":"JAMA"},{"key":"10058_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.breast.2019.12.004","volume":"49","author":"J Bajpai","year":"2020","unstructured":"Bajpai J, Kagwade S, Chandrasekharan A et al (2020) Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia. Breast 49:187\u2013193. https:\/\/doi.org\/10.1016\/j.breast.2019.12.004","journal-title":"Breast"},{"issue":"1","key":"10058_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clbc.2017.07.012","volume":"18","author":"HS Rugo","year":"2018","unstructured":"Rugo HS, Voigt J (2018) Scalp hypothermia for preventing alopecia during chemotherapy. A systematic review and meta-analysis of randomized controlled trials. Clin Breast Cancer 18(1):19\u201328. https:\/\/doi.org\/10.1016\/j.clbc.2017.07.012","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"10058_CR37","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/s0959-8049(00)00012-5","volume":"36","author":"P Katsimbri","year":"2000","unstructured":"Katsimbri P, Bamias A, Pavlidis N (2000) Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 36(6):766\u2013771. https:\/\/doi.org\/10.1016\/s0959-8049(00)00012-5","journal-title":"Eur J Cancer"},{"issue":"2","key":"10058_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1046\/j.1365-2354.2003.00382.x","volume":"12","author":"C Macduff","year":"2003","unstructured":"Macduff C, Mackenzie T, Hutcheon A, Melville L, Archibald H (2003) The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care (Engl) 12(2):154\u2013161. https:\/\/doi.org\/10.1046\/j.1365-2354.2003.00382.x","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"6","key":"10058_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00520-025-09526-2","volume":"33","author":"FFI Breed","year":"2025","unstructured":"Breed FFI, Breed WPM, Dercksen MW, Ezendam N, Bijlsma MJ, van den Hurk CJG (2025) Shorter post-infusion cooling times at least as effective as longer cooling times - an observational study of taxane- and anthracycline-based chemotherapies in the Dutch Scalp Cooling Registry. Support Care Cancer 33(6):503. https:\/\/doi.org\/10.1007\/s00520-025-09526-2","journal-title":"Support Care Cancer"},{"issue":"10","key":"10058_CR40","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1093\/oncolo\/oyae116","volume":"29","author":"TS Brook","year":"2024","unstructured":"Brook TS, Seetsen T, Dercksen MW et al (2024) Results of the Dutch scalp cooling registry in 7424 patients: analysis of determinants for scalp cooling efficacy. Oncologist 29(10):e1386\u2013e1395. https:\/\/doi.org\/10.1093\/oncolo\/oyae116","journal-title":"Oncologist"},{"issue":"4","key":"10058_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/jocd.12308","volume":"16","author":"A Rossi","year":"2017","unstructured":"Rossi A, Fortuna MC, Caro G et al (2017) Chemotherapy-induced alopecia management: clinical experience and practical advice. J Cosmet Dermatol 16(4):537\u2013541. https:\/\/doi.org\/10.1111\/jocd.12308","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"10058_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ijc.28961","volume":"136","author":"CM Soref","year":"2015","unstructured":"Soref CM, Fahl WE (2015) A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor. Int J Cancer 136(1):195\u2013203. https:\/\/doi.org\/10.1002\/ijc.28961","journal-title":"Int J Cancer"},{"issue":"2","key":"10058_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00002820-197904000-00005","volume":"2","author":"NC Lovejoy","year":"1979","unstructured":"Lovejoy NC (1979) Preventing hair loss during adriamycin therapy. Cancer Nurs 2(2):117\u2013121","journal-title":"Cancer Nurs"},{"key":"10058_CR44","first-page":"32","volume":"12","author":"Z Li","year":"1995","unstructured":"Li Z, Liu J, Zhuang X et al (1995) Clinical observation of the effects of hair band to alleviate theadriamycin and cyclophosphamide induced hair loss [in Chinese]. Pract Nurs 12:32\u201333","journal-title":"Pract Nurs"},{"issue":"21","key":"10058_CR45","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1056\/nejm197805252982121","volume":"298","author":"A Pesce","year":"1978","unstructured":"Pesce A, Cassuto JP, Joyner MV, DuJardin P, Audoly P (1978) Scalp tourniquet in the prevention of chemotherapy-induced alopecia. N Engl J Med 298(21):1204\u20131205. https:\/\/doi.org\/10.1056\/nejm197805252982121","journal-title":"N Engl J Med"},{"key":"10058_CR46","doi-asserted-by":"publisher","unstructured":"(1978) Scalp tourniquet in cancer therapy.\u00a0N Engl J Med 299(11):605-606. https:\/\/doi.org\/10.1056\/NEJM197809142991115","DOI":"10.1056\/NEJM197809142991115"},{"key":"10058_CR47","unstructured":"(2025) Cooler heads care inc. study to assess the ability of the portable scalp cooling system (PSCS) to prevent hair loss in women receiving chemotherapy for stage I-III breast cancer. ClinicalTrials.gov. NCT05484973. Accessed 11 June 2025"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10058-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10058-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10058-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T13:03:09Z","timestamp":1763211789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10058-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10058"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10058-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1005"}}